Literature DB >> 12010956

Mitral valve endocarditis in hypertrophic cardiomyopathy: case report and literature review.

G Morgan-Hughes1, J Motwani.   

Abstract

Mitral endocarditis complicating hypertrophic cardiomyopathy occurs predominantly on the left ventricular aspect of the anterior mitral valve leaflet in the presence of outflow tract obstruction. It is a rare condition and the estimated cumulative 10 year probability of developing endocarditis in patients with obstruction is < 5%. Combined mitral valve replacement and septal myectomy has been reported in this setting. A case of community acquired Staphylococcus aureus mitral valve endocarditis is reported in a previously asymptomatic young man with hypertrophic obstructive cardiomyopathy. The potential treatment options are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12010956      PMCID: PMC1767125          DOI: 10.1136/heart.87.6.e8

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  10 in total

Review 1.  Endocarditis: basics.

Authors:  S J Eykyn
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

2.  Hypertrophic obstructive cardiomyopathy associated with mitral regurgitation due to infective endocarditis.

Authors:  M Ninomiya; S Takamoto; Y Kotsuka; T Ohtsuka; K Ueno
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-12

Review 3.  Endocarditis: problems--patients being treated for endocarditis and not doing well.

Authors:  C M Oakley; R J Hall
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

Review 4.  Hypertrophic obstructive cardiomyopathy and infective endocarditis: a report of seven cases and a review of the literature.

Authors:  N Alessandri; G Pannarale; F del Monte; F Moretti; B Marino; A Reale
Journal:  Eur Heart J       Date:  1990-11       Impact factor: 29.983

5.  Hypertrophic obstructive cardiomyopathy. Initial results and long-term follow-up after Morrow septal myectomy.

Authors:  J M ten Berg; M J Suttorp; P J Knaepen; S M Ernst; F E Vermeulen; W Jaarsma
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

6.  Severe mitral or aortic valve regurgitation, or both, requiring valve replacement for infective endocarditis complicating hypertrophic cardiomyopathy.

Authors:  W C Roberts; J C Kishel; C L McIntosh; R O Cannon; B J Maron
Journal:  J Am Coll Cardiol       Date:  1992-02       Impact factor: 24.094

7.  Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results.

Authors:  B Heric; B W Lytle; D P Miller; E R Rosenkranz; H M Lever; D M Cosgrove
Journal:  J Thorac Cardiovasc Surg       Date:  1995-07       Impact factor: 5.209

8.  Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy.

Authors:  R C Robbins; E B Stinson
Journal:  J Thorac Cardiovasc Surg       Date:  1996-03       Impact factor: 5.209

9.  Surgical correction of hypertrophic obstructive cardiomyopathy: seventeen-year Green Lane experience.

Authors:  P Ponoth; A Kerr; P J Raudkivi; K Grahm; D Hydock; P Milson
Journal:  J Card Surg       Date:  1997 Sep-Oct       Impact factor: 1.620

10.  Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis.

Authors:  P Spirito; C Rapezzi; P Bellone; S Betocchi; C Autore; M R Conte; G P Bezante; P Bruzzi
Journal:  Circulation       Date:  1999-04-27       Impact factor: 29.690

  10 in total
  2 in total

1.  Actinobacillus endocarditis associated with hypertrophic cardiomyopathy.

Authors:  Vanda Cristina Jorge; Ana Carolina Araújo; Ana Grilo; Carla Noronha; António Panarra; Nuno Riso; Manuel Vaz Riscado
Journal:  BMJ Case Rep       Date:  2012-08-13

2.  Infective endocarditis complicating hypertrophic obstructive cardiomyopathy: is antibiotic prophylaxis really unnecessary?

Authors:  Ahmet Guler; Soe M Aung; Beytullah Cakal; Can Y Karabay; Yeliz Guler; Cevat Kirma
Journal:  Curr Cardiol Rev       Date:  2013-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.